Cargando…
Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe
Monoclonal antibodies have become a mainstay of treatment for many inflammatory diseases and malignancies. Multiple sclerosis is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system and a common cause of disability in young adults. Ocrelizumab is a recom...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865367/ https://www.ncbi.nlm.nih.gov/pubmed/35222433 http://dx.doi.org/10.3389/fimmu.2022.840238 |